The anti-Müllerian hormone (AMH) blood test and antral follicle count (AFC) ultrasound are the most accurate commonly used tests for estimating ovarian reserve. Both help doctors estimate how many eggs remain in the ovaries and predict how the ovaries may respond to fertility treatment. However, neither test can measure the exact number of remaining eggs or reliably predict whether someone will become pregnant naturally.
Which Ovarian Reserve Test Is the Most Reliable?
AMH and AFC are considered the most sensitive and reliable markers of ovarian reserve. They provide different ways to estimate the remaining egg supply, and research indicates that their performance in predicting ovarian response to fertility medications is generally comparable.
According to the American Society for Reproductive Medicine (ASRM), AMH and AFC are the simplest, most sensitive, and most specific available measures of ovarian reserve. AMH is generally more sensitive than traditional follicle-stimulating hormone (FSH) testing, while AFC is an equally reasonable option when performed by an experienced ultrasound specialist.
The most appropriate test depends on why ovarian reserve is being assessed. An AMH blood test may be more convenient for someone who wants an initial evaluation. An AFC ultrasound may be especially useful when an ultrasound examination is already part of fertility care.
How Does the AMH Blood Test Measure Ovarian Reserve?
Anti-Müllerian hormone is produced by cells surrounding developing eggs inside small ovarian follicles. Follicles are tiny fluid-filled sacs in the ovaries, each containing an immature egg.
Because AMH is produced by developing follicles, its level in the blood provides an indirect estimate of ovarian reserve. As the number of follicles decreases with age, AMH levels generally decline.
The MedlinePlus AMH testing guide explains that the test helps assess the remaining egg supply and predict the response to fertility medications. It cannot determine egg quality or establish whether pregnancy will occur.
Why Is AMH Often the Preferred Blood Test?
AMH offers several practical advantages over older ovarian reserve blood tests:
- It can usually be measured at any point during the menstrual cycle.
- It is more sensitive than FSH for detecting a decline in ovarian reserve.
- It requires only a blood sample rather than an ultrasound examination.
- It helps fertility specialists estimate the likely number of eggs retrieved during ovarian stimulation.
- It can provide useful information when planning medication doses for IVF treatment.
AMH levels are relatively stable throughout the menstrual cycle, although some variation can occur. Hormonal contraceptives may temporarily lower measured AMH levels, so the result should be interpreted with the patient's medication history in mind.
Is Antral Follicle Count More Accurate Than AMH?
Antral follicle count is generally as reliable as AMH for estimating ovarian reserve and predicting the number of eggs that may develop during IVF stimulation. Neither test consistently outperforms the other in every clinical situation.
AFC is measured using a transvaginal ultrasound. During the examination, a healthcare professional counts small follicles visible in both ovaries. The count is typically performed during the early part of the menstrual cycle.
According to Cleveland Clinic, ovarian reserve evaluation commonly includes AMH and FSH blood tests along with an AFC ultrasound. These measurements help estimate egg supply relative to age and predict the likely response to fertility treatment.
What Are the Advantages and Limitations of AFC?
AFC allows clinicians to see and count the small follicles that are currently visible in the ovaries. It may also be useful when other aspects of ovarian anatomy need to be examined.
However, AFC has limitations. The accuracy of the count depends partly on ultrasound image quality and the experience of the person performing the examination. It also counts visible small follicles rather than every remaining egg.
When performed in an experienced fertility center, AFC is a strong alternative to AMH testing.
AMH vs. AFC vs. FSH: Which Test Is Best?
The three commonly discussed ovarian reserve tests measure different biological signals. Their strengths and limitations help explain why AMH and AFC are generally preferred.
| Test | What It Measures | When It Is Done | Main Limitation |
|---|---|---|---|
| AMH blood test | Hormone produced by developing ovarian follicles | Usually any day of the menstrual cycle | Cannot measure egg quality or predict natural pregnancy |
| AFC ultrasound | Number of small visible follicles in both ovaries | Typically early in the menstrual cycle | Accuracy depends partly on ultrasound technique and expertise |
| FSH blood test | Hormone involved in stimulating follicle development | Usually menstrual cycle days 2–4 | Less sensitive to early ovarian reserve decline |
Why Is FSH Less Accurate for Early Ovarian Reserve Decline?
Follicle-stimulating hormone is released by the pituitary gland and helps follicles develop in the ovaries.
As ovarian reserve declines, FSH levels may increase. However, FSH can remain within the expected range even when the number of remaining follicles has already decreased.
This makes FSH less sensitive than AMH for identifying earlier changes in ovarian reserve. FSH levels also vary between menstrual cycles.
Estradiol, a form of estrogen, is sometimes measured alongside FSH because elevated early-cycle estradiol can make an FSH result appear less concerning than it otherwise would.
FSH and estradiol may still provide additional information in selected circumstances, particularly when AMH is very low or hormone results require further interpretation.
What Do Ovarian Reserve Test Results Actually Tell You?
Ovarian reserve results are best understood as estimates of egg quantity, not direct measurements of overall fertility.
What Does a Low AMH or AFC Result Mean?
A low AMH level or low antral follicle count may indicate that the ovaries have fewer remaining follicles than expected for someone of a similar age.
In fertility treatment, a lower ovarian reserve may be associated with fewer eggs developing in response to stimulation medications.
However, a low result does not establish infertility. People with low ovarian reserve measurements may still become pregnant naturally, and some may respond to IVF treatment.
Does a High AMH Result Mean Better Fertility?
A higher AMH level generally suggests a larger pool of developing ovarian follicles. It may also indicate a stronger response to medications used during IVF.
However, higher AMH does not necessarily mean healthier eggs or a higher chance of pregnancy.
Some people with polycystic ovary syndrome (PCOS) have elevated AMH levels because they have an increased number of small ovarian follicles. AMH alone cannot establish a diagnosis of PCOS.
Is There a Normal AMH Level for Every Age?
AMH generally decreases with age, but there is no single value that accurately defines fertility for every person.
Laboratories may use different measurement methods and reference ranges. A result considered lower than expected at one age may have a different meaning at another age.
For this reason, healthcare professionals interpret AMH alongside age, medical history, menstrual patterns, other test findings, and the reason testing was requested.
Can Ovarian Reserve Tests Predict Natural Pregnancy?
No ovarian reserve test can reliably predict an individual's ability to become pregnant naturally.
Ovarian reserve measures the estimated quantity of remaining eggs. Pregnancy depends on additional factors, including egg quality, ovulation, sperm health, and the reproductive organs.
The American College of Obstetricians and Gynecologists (ACOG) advises that a single AMH measurement should not be used to predict time to pregnancy in women without diagnosed infertility. Routine AMH testing solely to estimate future fertility is not supported by sufficient evidence.
This distinction is important because someone can have a low ovarian reserve measurement and still conceive naturally. Likewise, having a high ovarian reserve does not guarantee pregnancy.
Which Test Is Most Useful Before IVF?
AMH and AFC are both useful when planning in vitro fertilization (IVF). They help fertility specialists predict how the ovaries may respond to medications that stimulate several follicles to develop at once.
These measurements can help clinicians anticipate a lower or higher ovarian response and select an appropriate stimulation approach.
However, predicting how many eggs may be retrieved is different from predicting whether IVF will result in a live birth.
AMH and AFC have a much stronger relationship with egg yield than with egg quality or pregnancy outcomes. Age remains an important factor when estimating reproductive potential.
A very low ovarian reserve result should not automatically exclude someone from IVF treatment. Fertility specialists consider the broader clinical picture when discussing available options.
Is Using Both AMH and AFC More Accurate?
Using AMH and AFC together can give clinicians additional information, particularly when the results appear inconsistent or when ultrasound findings are needed for treatment planning.
However, routinely combining multiple ovarian reserve tests does not consistently improve prediction compared with using a reliable AMH or AFC measurement alone.
In some cases, the two tests may produce different impressions of ovarian reserve. This does not necessarily mean either result is incorrect. Differences in testing methods, biological variation, and ultrasound assessment may contribute.
Rather than automatically ordering every available ovarian reserve test, a fertility specialist can select the assessment most useful for the clinical question.
When Should You Consider Ovarian Reserve Testing?
Ovarian reserve testing may be appropriate when the results can help guide fertility-related decisions. Situations in which a clinician may recommend testing include:
- Preparing for IVF or another fertility treatment involving ovarian stimulation.
- Undergoing an infertility evaluation where ovarian response information may affect planning.
- Having a medical history or previous treatment that may have affected ovarian function.
- Discussing fertility preservation when there are specific medical or reproductive concerns.
Testing is not necessarily helpful for everyone who is curious about future fertility. In someone without infertility or another specific medical reason for testing, an AMH result alone may create unnecessary concern or false reassurance.
For people trying to conceive, fertility evaluation is generally recommended after 12 months of regular unprotected intercourse if younger than 35, or after 6 months if aged 35 or older. Those over 40 or with known fertility-related concerns may benefit from earlier evaluation.
What Is the Most Accurate Way to Assess Ovarian Reserve Overall?
For estimating the remaining egg supply, AMH and AFC remain the leading ovarian reserve assessments. AMH offers a convenient blood-based measurement, while AFC provides a direct ultrasound count of visible small follicles.
Neither test can count every remaining egg, evaluate egg quality, or accurately predict natural conception. Adding more tests does not automatically make the assessment more accurate.
The most useful approach is to choose AMH or AFC based on the clinical purpose and interpret the result alongside age, reproductive history, and other relevant findings. A gynecologist or fertility specialist can explain what the result means and whether any additional evaluation would change care decisions.